---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-010071"
form_type: "8-K"
ticker: "COCP"
cik: "0001412486"
company_name: "Cocrystal Pharma, Inc."
filed_at: "2026-03-13T23:59:59+00:00"
generated_at: "2026-05-15T12:27:56.197803+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Cocrystal Pharma board member Dr. Anthony Japour passes away on March 10, 2026

## Summary
- Dr. Anthony Japour, a member of Cocrystal Pharma's board of directors, died on March 10, 2026.
- The company reported the sad event in a Form 8-K filed March 13, 2026.
- No replacement or further board changes announced as of the filing date.
- Dr. Japour's passing reduces the board size; no other details provided.

## SEC filing metadata
- accession: 0001493152-26-010071
- form_type: 8-K
- ticker: COCP
- cik: 0001412486
- company_name: Cocrystal Pharma, Inc.
- filed_at: 2026-03-13T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1412486/000149315226010071/0001493152-26-010071-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1412486/000149315226010071/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-010071
- JSON: https://secwatch.observer/filing/0001493152-26-010071.json
- Plain text: https://secwatch.observer/filing/0001493152-26-010071.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.